Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02402920
Title Phase I Trial of MK-3475 and Concurrent Chemo/Radiation for the Elimination of Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

lung small cell carcinoma

neuroendocrine tumor

Therapies

Carboplatin + Etoposide + Pembrolizumab

Cisplatin

Age Groups: adult
Covered Countries USA


No variant requirements are available.